Global market valuation was derived through revenue mapping, unit shipment analysis, and procedure/installation volume assessment. The methodology included:
Identification of 50+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America, including specialized exoskeleton developers (Ekso Bionics, ReWalk Robotics, Cyberdyne, Sarcos Robotics, Lockheed Martin), diversified industrial automation companies (Honda, Parker Hannifin, Hyundai), and emerging soft exosuit developers
Product mapping across powered exoskeletons, passive exoskeletons, soft exosuits, and hybrid systems by application vertical (healthcare/rehabilitation, industrial manufacturing, logistics/warehousing, military/defense, construction)
Technology segmentation across electric actuation, hydraulic systems, pneumatic systems, and hybrid power sources; and control interfaces including myoelectric sensors, EEG-based control, human-machine interface (HMI) systems, and voice control
Analysis of reported and modeled annual revenues specific to exoskeleton product portfolios, including hardware sales, software/services, and maintenance contracts
Coverage of manufacturers representing 75-80% of global market share in 2024
Extrapolation using bottom-up (unit shipments × ASP by country/region, installation volumes by industry vertical, rehabilitation session metrics) and top-down (manufacturer revenue validation, industry spending analysis, defense procurement budgets) approaches to derive segment-specific valuations and growth projections through 2035